Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vernalis plc
Researches and develops pharmaceutical products

Vernalis Plc is a research and development stage pharmaceutical company.

The company provides pharmaceutical products for a range of medical disorders.

It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.

The group has one marketed product, frovatriptan, for the acute treatment of migraines, as well as eight programmes in its NCE development pipeline.

The company was founded by Keith G. McCullagh in 1986 and is headquartered in Wokingham, the United Kingdom.

Number of employees : 89 persons.
Sales per Businesses
20122013Delta
GBP (in Million)%GBP (in Million)%
Pharmaceuticals14.62100%14.08100% -3.78%
Managers
NameAgeSinceTitle
Allan J. Baxter, PhD642004Independent Non-Executive Director
Carol C. Ferguson672003Senior Independent Non-Executive Director
Peter John Fellner, PhD702003Non-Executive Chairman
Ian Garland482008Chief Executive Officer & Executive Director
David MacKney462009Chief Financial Officer & Executive Director
Mike Wood-2004Research Director
Nerida Scott, PhD-2002Director-Business Development & Licensing
Nigel Sheail482011Independent Non-Executive Director
Kevin Kissane582010Secretary & General Counsel
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
PHARMACYCLICS, IN..
INCYTE CORPORATIO..
INTERMUNE INC
PUMA BIOTECHNOLOG..
-
QUINTILES TRANSNA..
ALKERMES PLC
QIAGEN NV
UNITED THERAPEUTI..
SEATTLE GENETICS,..
ALNYLAM PHARMACEU..
ISIS PHARMACEUTIC..
COVANCE INC.
TECHNE CORPORATIO..
PAREXEL INTERNATI..
ICON PLC
CHARLES RIVER LAB..
WUXI PHARMATECH (..
MORPHOSYS AG
SYNAGEVA BIOPHARM..
ACADIA PHARMACEUT..
Sector Biotechnology & Medical Research
Company contact information
Vernalis Plc
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire RG41 5RD

Phone : +44.118.938.0000
Fax : +44.118.938.0001
Web : www.vernalis.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF